planinin has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, JH; He, LH; Tang, CK; Wan, XJ; Wang, G; Wen, FJ; Yu, XH; Zhao, ZW; Zhou, L; Zou, J | 1 |
| Cheng, Y; Li, X; Wang, X; Xue, H; Yue, Y; Zhang, W | 1 |
2 other study(ies) available for planinin and Disease Models, Animal
| Article | Year |
|---|---|
Fargesin alleviates atherosclerosis by promoting reverse cholesterol transport and reducing inflammatory response.
Topics: Administration, Oral; Animals; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; Benzodioxoles; Cholesterol; Diet, High-Fat; Disease Models, Animal; Humans; Lignans; Lipid Metabolism; Male; Mice; Mice, Knockout, ApoE; NF-kappa B; Signal Transduction; THP-1 Cells; Toll-Like Receptor 4; Up-Regulation | 2020 |
Fargesin as a potential β₁ adrenergic receptor antagonist protects the hearts against ischemia/reperfusion injury in rats via attenuating oxidative stress and apoptosis.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Apoptosis; Benzodioxoles; Cardiotonic Agents; Catalase; CHO Cells; Creatine Kinase; Cricetulus; Disease Models, Animal; Glutathione Peroxidase; Heart; L-Lactate Dehydrogenase; Lignans; Malondialdehyde; Molecular Structure; Myocardium; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Superoxide Dismutase | 2015 |